JBC Oz Biosciences

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M405502200 on October 8, 2004

J. Biol. Chem., Vol. 279, Issue 51, 53116-53125, December 17, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/51/53116    most recent
M405502200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, Y.
Right arrow Articles by Kraft, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, Y.
Right arrow Articles by Kraft, A. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Phorbol Ester Treatment of K562 Cells Regulates the Transcriptional Activity of AML1c through Phosphorylation*

Youhong Zhang, Joseph R. Biggs{ddagger}, and Andrew S. Kraft§

From the Hollings Cancer Center, the Medical University of South Carolina, Charleston, South Carolina 29425

We find that phorbol ester (PE) treatment of K562 cells greatly stimulates promoters (T cell receptor {beta}, myeloperoxidase, macrophage colony-stimulating factor receptor, and granulocyte macrophage colony-stimulating factor receptor) containing AML1 transcription factor binding sites. This stimulation of AML1c transcriptional activity is mediated by direct phosphorylation of the AML1c molecule on multiple phosphorylation sites. Eleven AML1c (S/T)P sites in the transcriptional activating domain are phosphorylated at a basal level in untreated K562 cells; treatment of the K562 cells with PE results in increased phosphorylation at five of these sites (serines 276, 293, 303, 462, and threonine 300). Mutation of these five sites to alanine inhibits PE-induced transcriptional activity; mutation of the sites to an acidic amino acid, aspartic acid, stimulates constitutive activity. Single mutations in four amino acids or double mutations (serines 276 and 293 or threonine 300 and serine 303) have little effect on AML1c transcriptional activity. Inhibitor assays suggest that the ERK family of protein kinases is activated by PEs to phosphorylate the (S/T)P sites within the AML1c molecule and markedly enhance the transcriptional activity of AML1c.


Received for publication, May 17, 2004 , and in revised form, September 30, 2004.

* This work was supported by National Institutes of Health Grant CA42533 (to A. S. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} Present address: The Scripps Research Institute, 10550 North Torrey Pines Rd., La Jolla, CA 92037.

§ To whom correspondence should be addressed: Hollings Cancer Center, the Medical University of South Carolina, 86 Jonathan Lucas St., Charleston, SC 29425. Tel.: 843-792-8284; Fax: 843-792-9456; E-mail: Kraft{at}musc.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
L. Zhang, F. B. Fried, H. Guo, and A. D. Friedman
Cyclin-dependent kinase phosphorylation of RUNX1/AML1 on 3 sites increases transactivation potency and stimulates cell proliferation
Blood, February 1, 2008; 111(3): 1193 - 1200.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. R. Biggs, L. F. Peterson, Y. Zhang, A. S. Kraft, and D.-E. Zhang
AML1/RUNX1 Phosphorylation by Cyclin-Dependent Kinases Regulates the Degradation of AML1/RUNX1 by the Anaphase-Promoting Complex
Mol. Cell. Biol., October 15, 2006; 26(20): 7420 - 7429.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
Z. Yuan, A. Tie, M. Tarnopolsky, and M. Bakovic
Genomic organization, promoter activity, and expression of the human choline transporter-like protein 1
Physiol Genomics, September 14, 2006; 26(1): 76 - 90.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
V. Hamelin, C. Letourneux, P.-H. Romeo, F. Porteu, and M. Gaudry
Thrombopoietin regulates IEX-1 gene expression through ERK-induced AML1 phosphorylation
Blood, April 15, 2006; 107(8): 3106 - 3113.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
J. E. Phillips, C. A. Gersbach, A. M. Wojtowicz, and A. J. Garcia
Glucocorticoid-induced osteogenesis is negatively regulated by Runx2/Cbfa1 serine phosphorylation
J. Cell Sci., February 1, 2006; 119(3): 581 - 591.
[Abstract] [Full Text] [PDF]


Home page
ASH ANNUAL MEETING ABSTRACTSHome page
S. Wang, Y. Zhang, J. R. Biggs, D.-E. Zhang, and A. S. Kraft
Phosphorylation of AML1 (RUNX1) Controls Transcription, Nuclear Localization, and Is Regulated during DNA Damage.
Blood (ASH Annual Meeting Abstracts), November 16, 2005; 106(11): 2712 - 2712.
[Abstract]


Home page
Mol Cancer ResHome page
J. R. Biggs, Y. Zhang, L. F. Peterson, M. Garcia, D.-E. Zhang, and A. S. Kraft
Phosphorylation of AML1/RUNX1 Regulates Its Degradation and Nuclear Matrix Association
Mol. Cancer Res., July 1, 2005; 3(7): 391 - 401.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.